Cholesterol production, accumulation, reverse transport, and excretion: opportunities for statins, PPAR-α agonists, and PCSK9 inhibitors
No transcript available.
Cholesterol production, accumulation, reverse transport, and excretion: opportunities for statins, PPAR-α agonists, and PCSK9 inhibitors